Fourth Annual “Plateaux Pharma Expo” to Showcase Algeria's Pharmaceutical Industry
Image: Echorouk
Takeaway
The Plateaux Pharma Expo and Maghreb Pharma Expo provide opportunities for international investors and pharmaceutical companies to assess the growing Algerian market. Companies should analyze the trends showcased at these events to identify potential partnerships and investment opportunities, particularly in local manufacturing and drug delivery systems. Monitoring government regulations and incentives will be crucial for navigating the evolving landscape.
The fourth edition of the “Plateaux Pharma Expo” is scheduled to take place from April 30 to May 2, 2026, in Setif, Algeria. Organized by “Sojax”, the event will host approximately 80 leading national institutions specializing in the pharmaceutical and parapharmaceutical industries. The exhibition aims to foster professional collaboration and address challenges within Algeria's pharmaceutical market. The event is held under the high patronage of the Wali of Setif and in coordination with local authorities.
Algeria's pharmaceutical industry has been targeted as a model sector for diversification, with 218 active factories in 2025 covering over 70% of the country's drug needs through local production. The government aims for $10 to $15 billion in non-hydrocarbon exports by 2026, with the pharmaceutical industry playing a key role. In 2023, the Algerian pharmaceutical market was estimated at USD 4 billion, demonstrating double-digit growth of 17% over the past decade. Government policies incentivize local production by gradually reducing imports and offering tax incentives.
Maghreb Pharma Expo, another significant pharmaceutical event in Algeria, will be held from April 21-23, 2026, at the SAFEX Exhibition Center in Algiers. This expo is considered Africa's largest pharmaceutical technology trade fair. Maghreb Pharma Expo anticipates over 250 exhibitors and thousands of visitors, serving as a crucial platform for industry stakeholders in Algeria and the broader Maghreb region. The event showcases innovations in equipment, packaging, raw materials, and pharmaceutical technologies. Key areas of focus include pharmaceutical ingredients, production lines, packaging solutions, cleanroom technologies, and laboratory equipment.
The Algerian government is actively working to modernize the pharmaceutical industry, as demonstrated by the establishment of the Ministry of Pharmaceutical Industry (MOPI) and the National Agency for Pharmaceutical Products (ANPP). These organizations are addressing critical issues such as drug pricing, regulations, and marketing operations. MOPI has also issued regulations to decrease wait times for registering new drugs. The pharmaceutical industry is considered a locomotive for the Algerian general industry, experiencing double-digit growth over the past twenty years.
The Algeria Pharmaceutical Drug Delivery Market is projected to reach USD 324.53 million by 2032, growing at a CAGR of 8.66% from USD 159.38 million in 2024. The northern region of Algeria holds the largest market share at 55%, followed by the central region at 30% and the southern region at 15%. The Algeria active pharmaceutical ingredients market is expected to reach USD 751.3 million by 2030, growing at a CAGR of 6.4% from a revenue of USD 485.8 million in 2023. Investors should monitor the implementation of government policies aimed at increasing local production and reducing import dependence, as well as the outcomes of industry events like Plateaux Pharma Expo and Maghreb Pharma Expo.